Cargando…
Stereology in Grading and Prognosis of Canine Cutaneous Mast Cell Tumors
Canine cutaneous mast cell tumors (ccMCTs) are currently graded according to Patnaik and Kiupel grading schemes. The qualitative and semiquantitative parameters applied in these schemes may lead to inter- and intraobserver variability. This study investigates the prognostic value of volume-weighted...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064533/ https://www.ncbi.nlm.nih.gov/pubmed/33576305 http://dx.doi.org/10.1177/0300985820985138 |
_version_ | 1783682156052086784 |
---|---|
author | Casanova, Mafalda Branco, Sandra Veiga, Inês Berenguer Barros, André Faísca, Pedro |
author_facet | Casanova, Mafalda Branco, Sandra Veiga, Inês Berenguer Barros, André Faísca, Pedro |
author_sort | Casanova, Mafalda |
collection | PubMed |
description | Canine cutaneous mast cell tumors (ccMCTs) are currently graded according to Patnaik and Kiupel grading schemes. The qualitative and semiquantitative parameters applied in these schemes may lead to inter- and intraobserver variability. This study investigates the prognostic value of volume-weighted mean nuclear volume ([Formula: see text]), a stereological estimation that provides information about nuclear size and its variability. [Formula: see text] of 55 ccMCTs was estimated using the “point-sampled intercept” method and compared with histological grade and clinical outcome. The clinical history of dogs treated with surgical excision alone was available for 30 ccMCTs. Statistical differences in [Formula: see text] were found between grade II ([Formula: see text] = 115 ± 29 µm(3)) and grade III ccMCTs ([Formula: see text] = 197 ± 63 µm(3)), as well as between low-grade ([Formula: see text] = 113 ± 28 µm(3)) and high-grade ccMCTs ([Formula: see text] = 184 ± 63 µm(3)). An optimal cutoff value of [Formula: see text] ≥ 150 µm(3) and [Formula: see text] ≥ 140 µm(3) was determined for grade III and high-grade ccMCTs, respectively. In terms of prognosis, [Formula: see text] was not able to predict the clinical outcome in 42% of the cases; however, cases with [Formula: see text] <125 µm(3) had a favorable outcome. These results indicate that, despite having limited prognostic value when used as a solitary parameter, [Formula: see text] is highly reproducible and is associated with histological grade as well as with benign behavior. |
format | Online Article Text |
id | pubmed-8064533 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-80645332021-05-13 Stereology in Grading and Prognosis of Canine Cutaneous Mast Cell Tumors Casanova, Mafalda Branco, Sandra Veiga, Inês Berenguer Barros, André Faísca, Pedro Vet Pathol Oncology Canine cutaneous mast cell tumors (ccMCTs) are currently graded according to Patnaik and Kiupel grading schemes. The qualitative and semiquantitative parameters applied in these schemes may lead to inter- and intraobserver variability. This study investigates the prognostic value of volume-weighted mean nuclear volume ([Formula: see text]), a stereological estimation that provides information about nuclear size and its variability. [Formula: see text] of 55 ccMCTs was estimated using the “point-sampled intercept” method and compared with histological grade and clinical outcome. The clinical history of dogs treated with surgical excision alone was available for 30 ccMCTs. Statistical differences in [Formula: see text] were found between grade II ([Formula: see text] = 115 ± 29 µm(3)) and grade III ccMCTs ([Formula: see text] = 197 ± 63 µm(3)), as well as between low-grade ([Formula: see text] = 113 ± 28 µm(3)) and high-grade ccMCTs ([Formula: see text] = 184 ± 63 µm(3)). An optimal cutoff value of [Formula: see text] ≥ 150 µm(3) and [Formula: see text] ≥ 140 µm(3) was determined for grade III and high-grade ccMCTs, respectively. In terms of prognosis, [Formula: see text] was not able to predict the clinical outcome in 42% of the cases; however, cases with [Formula: see text] <125 µm(3) had a favorable outcome. These results indicate that, despite having limited prognostic value when used as a solitary parameter, [Formula: see text] is highly reproducible and is associated with histological grade as well as with benign behavior. SAGE Publications 2021-02-12 2021-05 /pmc/articles/PMC8064533/ /pubmed/33576305 http://dx.doi.org/10.1177/0300985820985138 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Oncology Casanova, Mafalda Branco, Sandra Veiga, Inês Berenguer Barros, André Faísca, Pedro Stereology in Grading and Prognosis of Canine Cutaneous Mast Cell Tumors |
title | Stereology in Grading and Prognosis of Canine Cutaneous Mast Cell Tumors |
title_full | Stereology in Grading and Prognosis of Canine Cutaneous Mast Cell Tumors |
title_fullStr | Stereology in Grading and Prognosis of Canine Cutaneous Mast Cell Tumors |
title_full_unstemmed | Stereology in Grading and Prognosis of Canine Cutaneous Mast Cell Tumors |
title_short | Stereology in Grading and Prognosis of Canine Cutaneous Mast Cell Tumors |
title_sort | stereology in grading and prognosis of canine cutaneous mast cell tumors |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064533/ https://www.ncbi.nlm.nih.gov/pubmed/33576305 http://dx.doi.org/10.1177/0300985820985138 |
work_keys_str_mv | AT casanovamafalda stereologyingradingandprognosisofcaninecutaneousmastcelltumors AT brancosandra stereologyingradingandprognosisofcaninecutaneousmastcelltumors AT veigainesberenguer stereologyingradingandprognosisofcaninecutaneousmastcelltumors AT barrosandre stereologyingradingandprognosisofcaninecutaneousmastcelltumors AT faiscapedro stereologyingradingandprognosisofcaninecutaneousmastcelltumors |